These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26585744)

  • 21. Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks.
    Minder CM; Blumenthal RS; Blaha MJ
    Curr Opin Cardiol; 2013 Sep; 28(5):554-60. PubMed ID: 23928920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials.
    Thavendiranathan P; Bagai A; Brookhart MA; Choudhry NK
    Arch Intern Med; 2006 Nov; 166(21):2307-13. PubMed ID: 17130382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis.
    Zhai C; Hou K; Li R; Hu Y; Zhang J; Zhang Y; Wang L; Zhang R; Cong H
    J Int Med Res; 2020 Jun; 48(6):300060520926349. PubMed ID: 32529863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin therapy in the elderly: a review.
    Szadkowska I; Stanczyk A; Aronow WS; Kowalski J; Pawlicki L; Ahmed A; Banach M
    Arch Gerontol Geriatr; 2010; 50(1):114-8. PubMed ID: 19217673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins for Primary Prevention of Cardiovascular Disease: Review of Evidence and Recommendations for Clinical Practice.
    Kazi DS; Penko JM; Bibbins-Domingo K
    Med Clin North Am; 2017 Jul; 101(4):689-699. PubMed ID: 28577620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits and Risks Associated With Statin Therapy for Primary Prevention in Old and Very Old Adults : Real-World Evidence From a Target Trial Emulation Study.
    Xu W; Lee AL; Lam CLK; Danaei G; Wan EYF
    Ann Intern Med; 2024 Jun; 177(6):701-710. PubMed ID: 38801776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update for primary healthcare providers: recent statin trials and revised National Cholesterol Education Program III guidelines.
    Hennekens CH; Hollar D; Eidelman RS; Agatston AS
    MedGenMed; 2006 Feb; 8(1):54. PubMed ID: 16915184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
    Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
    Naci H; Brugts J; Ades T
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):390-9. PubMed ID: 23838105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Women Versus Men: Is There Equal Benefit and Safety from Statins?
    Plakogiannis R; Arif SA
    Curr Atheroscler Rep; 2016 Feb; 18(2):6. PubMed ID: 26782824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
    Yebyo HG; Aschmann HE; Puhan MA
    Ann Intern Med; 2019 Jan; 170(1):1-10. PubMed ID: 30508425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dyslipidaemias in elderly patients].
    Yıldırım AB; Kılınç AY
    Turk Kardiyol Dern Ars; 2017 Sep; 45(Suppl 5):25-28. PubMed ID: 28976376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Does statin therapy reduce the risk of stroke? A meta-analysis].
    Sirol M; Bouzamondo A; Sanchez P; Lechat P
    Ann Med Interne (Paris); 2001 Apr; 152(3):188-93. PubMed ID: 11431579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.
    Izzo R; de Simone G; Trimarco V; Giudice R; De Marco M; Di Renzo G; De Luca N; Trimarco B
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1101-6. PubMed ID: 23419735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins Provide Less Benefit in Populations with High Noncardiovascular Mortality Risk: Meta-Regression of Randomized Controlled Trials.
    Kim CA; Kim DH
    J Am Geriatr Soc; 2015 Jul; 63(7):1413-9. PubMed ID: 26173475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Statins in primary prevention - a must for the general practitioner?].
    Zoller M
    Praxis (Bern 1994); 2011 Jul; 100(14):859-60. PubMed ID: 21732299
    [No Abstract]   [Full Text] [Related]  

  • 39. Meta-analysis of Placebo-Controlled Randomized Controlled Trials on the Prevalence of Statin Intolerance.
    Riaz H; Khan AR; Khan MS; Rehman KA; Alansari SAR; Gheyath B; Raza S; Barakat A; Luni FK; Ahmed H; Krasuski RA
    Am J Cardiol; 2017 Sep; 120(5):774-781. PubMed ID: 28779871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Statin therapy--for whom?].
    Kahri J; Syvänne M
    Duodecim; 2012; 128(8):811-8. PubMed ID: 22616372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.